Related Experiment Video

Updated: May 18, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Deciphering the epigenetic network in colorectal cancer

Gemma Domínguez1

  • 1Departamento de Medicina, Facultad de Medicina, Universidad Autónoma de Madrid, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. gemma.dominguez@uam.es

The Journal of Pathology
|September 7, 2012
PubMed

Insights

Epigenetic changes, specifically microRNA (miRNA) deregulation, are crucial in colorectal cancer development. Researchers found miR-149 is silenced by methylation, targeting Sp1, with significant implications for prognosis and therapy.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Colorectal cancer (CRC) progression is traditionally linked to genetic mutations.
  • Emerging evidence highlights the critical role of epigenetic alterations in CRC development.
  • MicroRNA (miRNA) deregulation is a significant area of focus in cancer research.

Purpose of the Study:

  • To investigate the role of specific microRNAs in colorectal cancer.
  • To identify epigenetic mechanisms silencing key tumor-suppressive miRNAs in CRC.
  • To explore the functional targets and implications of dysregulated miRNAs in colorectal cancer.

Main Methods:

  • Analysis of gene methylation patterns in colorectal cancer tissues.
  • Quantitative real-time PCR to assess miRNA expression levels.
  • Western blotting and luciferase assays to validate miRNA targets.

Main Results:

  • miR-149 was found to be significantly downregulated in colorectal cancer.
  • Methylation of the miR-149 promoter was identified as the mechanism for its silencing.
  • Sp1 was confirmed as a direct target gene regulated by miR-149.

Conclusions:

  • Epigenetic silencing of miR-149 via methylation is a key event in colorectal cancer.
  • The miR-149/Sp1 axis represents a novel pathway with potential prognostic and therapeutic relevance in CRC.
  • Targeting epigenetic modifications could offer new therapeutic strategies for colorectal cancer.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...